Matrix Service Company announced it will release its first quarter Fiscal 2027 financial results after market close on November 4, 2026. The company will host a conference call on November 5 at 10:30 a.m. Eastern time to discuss the results and provide a forward outlook. This update is important for investors tracking the performance of this leading heavy industrial contractor in energy and infrastructure sectors. The call will be accessible via webcast and recorded for later replay.
Matrix Service Company sets the date for its Fiscal Year 2027 first quarter results release and conference call. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Oct 20, 2026 03:01 WIB: of 135 priced US Industrials stocks, 46 rose and 88 fell. Notable movers include TE at USD 2.53 with a 1-day change of -3.44% and a typical hold time of 5 days, CHRW at USD 144.20 up 3.41% with a typical hold time of 28 days, and FRO at USD 50.71 down 3.39%, with Pluang order activity showing 0% Sell / 100% Buy and a typical hold time of 4 days.
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
